Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Acquisitions Reshape the Bio/Pharm Services Industry

December 2, 2012

Pharmaceutical Technology

The quest to build critical mass and broaden capabilities has been a key factor in deal-making.

Designing a Clean-in-Place System

November 21, 2012

Equipment and Processing Report

An efficient cleaning cycle begins with equipment and automation-system design.

Advice for Enhancing the Client–Sponsor Relationship

November 2, 2012

Pharmaceutical Technology

Key talks from the recent PDA/FDA regulatory conference highlight room for improvement.

Creating a Holistic Procurement System

November 2, 2012

Pharmaceutical Technology

The procurement organization rethinks sourcing for maximum efficiency and results.

Stability Program Management

November 2, 2012

Pharmaceutical Technology

To support global stability practices, fundamental basics must be in place.

Patheon to Acquire Banner Pharmacaps

October 31, 2012

Patheon will acquire softgel-specialist company Banner Pharmacaps, based in North Carolina in the US, for $255 million

Considerations for Outsourcing Stability Storage

October 17, 2012
Equipment and Processing Report

Consider the time and expertise needed to maintain regulatory compliance and perform stability testing.

Challenges in Topical Drug Manufacturing

October 17, 2012

Equipment and Processing Report

Consider these tools and strategies for optimizing the manufacturing process.

Partnerships Remain Crucial to Future Development

October 2, 2012

Pharmaceutical Technology

Working together affords many unseen opportunities for pharmaceutical innovation.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
17%
Protecting the supply chain
50%
Expedited reviews of drug submissions
0%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here